news & events

Wednesday, Sept.8, 2010. CED Biotech Forum: The FDA Today
Wednesday, Sept. 15, 2010. Medical Innovation and Strategies Conference 2010
Wednesday, Sept. 29, 2010. Forsyth Tech SciTech Lecture Series: “Advancing Cancer Treatment through
Technology Innovation” Dr. Frank Torti, Wake Forest University Health Sciences
Comprehensive Cancer Center
Monday-Tuesday, October 4-5, 2010. HDMA Medical Product Commercialization Seminar: Leveraging Distribution to Commercialize New Products.
Wednesday, October 6, 2010 NCBIO Annual Meeting: A look at North Carolina's Vaccine Cluster: Present and Future
Monday-Wednesday, October 18-20, 2010. AdvaMed MedTech Conference
Monday-Tuesday, Oct. 18-19, 2010. SBS Biomolecular Screening Symposium
Wednesday, Oct. 27, 2010. Forsyth Tech SciTech Lecture Series: “The Benefits of 25 Years of HIV Research
on Laboratory Technology and Human Health” Dr. Mark Wainberg, McGill University, Past President of the International AIDS Society
Monday, Nov. 15, 2010. Forsyth Tech SciTech Lecture Series: “Biofuels Across the Landscape: Vision, Challenge, and Change” Steven Burke, CEO, Biofuels Center of North Carolina
Tuesday, November 30, 2010. ibiliti MedTech Conference
Thursday, Jan. 20, 2011. Forsyth Tech SciTech Lecture Series:“Environmental Health Science Curriculum Development in Liberia, West Africa” Dr. Frank Carver, Coordinator, Environmental Sciences, Forsyth Tech
Thursday, Feb. 3, 2011. Forsyth Tech SciTech Lecture Series: “Regenerative Medicine: New Approaches to Healthcare”
Dr. Anthony Atala, Wake Forest Institute for Regenerative Medicine
Thursday, March 17, 2011. Forsyth Tech SciTech Lecture Series:“The Targacept Story: From the Bench to the Clinic” Dr. J. Donald deBethizy, CEO & President, Targacept

More information on News and Events Page

mission

NCBIO is North Carolina's state-level affiliate of the national Biotechnology Industry Organization. Together, the two groups advocate federal, state and local public policies designed to help the bioscience industry fulfill its extraordinary promise as a source of economic opportunity and improved life quality.

advocacy highlights

Capital Access. Capital is a critical need of all bioscience companies. NCBIO works constantly to expand public investments in bioscience companies and life-science venture funds, loans for bioscience businesses, and tax incentives for investments and research.
Workforce Training and Education. Bioscience companies require highly educated scientists, laboratory technicians, manufacturing workers and other trained employees. North Carolina is spending more than $60 million on the new NCBIOIMPACT training consortium proposed by NCBIO. NCBIO is coordinating industry support and input for the Consortium.
University Research and Technology Transfer. Basic research is a wellspring of bioscience technology and business growth. NCBIO works to expand state funding for life science research grants and to protect and enhance university access to federal research dollars.
Tax and Regulatory Issues. Bioscience companies grow best in a nurturing business climate. NCBIO supports favorable tax treatment for biomanufacturing research and manufacturing expansions, government support for bioscience-related infrastructure. The Organization also aggressively opposes initiatives that depress the price of drugs and other health care products and seeks to assure that any new regulation of bioscience technologies is both necessary and rationale

As a key source of highly trained workers and the research that fuels innovation, higher education is critical to North Carolina's economic future. NCBIO has been an important advocate for expanded educational and research opportunities for our students, just as it has strongly supported new opportunities for the state's bioscience companies.

Join Us